FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Gentamicin Sulfate Injection
Status: Currently in Shortage
»Date first posted: 07/23/2021
»Therapeutic Categories: Anti-Infective

Expand all

Fresenius Kabi USA, LLC (Revised 09/23/2021)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
80 mg per 2 mL (40 mg per mL), MDV, (NDC 63323-010-02) Available Check wholesaler inventory Manufacturing delay
800 mg per 20 mL (40 mg per mL), MDV, (NDC 63323-010-20) Backordered. Next release October 2021. Check wholesaler inventory
20 mg per 2 mL (10 mg per mL), Pediatric SDV, (NDC 63323-173-02) Backordered. Next release September 2021. Check wholesaler inventory Manufacturing delay

Hospira, Inc. (Reverified 09/22/2021)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
80 mg/2 mL (40 mg/mL); 2 mL Single Dose Glass Fliptop Vial (NDC 00409-1207-03) Next Delivery and Estimated Recovery: November 2021 Demand increase for the drug
80 mg/2 mL (40 mg/mL) Single Dose Glass Fliptop Vial NovaPlus (NDC 00409-1207-25) Limited Supply Available. Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English